SPY304.32+1.35 0.45%
DIA254.29-0.06 -0.02%
IXIC9,489.87+120.88 1.29%

Oppenheimer Maintains Outperform on Cue Biopharma, Raises Price Target to $32

Oppenheimer maintains Cue Biopharma (NASDAQ:CUE) with a Outperform and raises the price target from $27 to $32.

Benzinga · 05/20/2020 12:24

Oppenheimer maintains Cue Biopharma (NASDAQ:CUE) with a Outperform and raises the price target from $27 to $32.